Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials

Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials

Peritoneal metastases from gastric cancer play a key role in the fatal prognosis of the disease. The lack of efficacy of actual therapeutic approaches together with the outcomes achieved with checkpoint inhibitors in gastric cancer compel us to address the current state-of-the-art immunotherapy trea...

Full description

Bibliographic Details
Main Authors: Eva Ruiz Hispán, Manuel Pedregal, Ion Cristobal, Jesús García-Foncillas, Cristina Caramés
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
gastric cancer
peritoneal metastasis
cytoreductive surgery
intraperitoneal chemotherapy
research
immunotherapy
Online Access:https://www.mdpi.com/2077-0383/10/20/4649

Internet

https://www.mdpi.com/2077-0383/10/20/4649

Similar Items